Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation

With the current widespread use of dolutegravir in low-income countries, the understanding of the impact of nucleoside reverse transcriptase inhibitor (NRTI-) associated mutations on the efficacy of dolutegravir-containing antiretroviral therapy (ART) is of utmost importance. We describe a rare case...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Dominique L., Scheier, Thomas, Ledermann, Ulrich, Flepp, Markus, Metzner, Karin J., Böni, Jürg, Günthard, Huldrych F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699495/
https://www.ncbi.nlm.nih.gov/pubmed/33228206
http://dx.doi.org/10.3390/v12111330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699495/
https://www.ncbi.nlm.nih.gov/pubmed/33228206
http://dx.doi.org/10.3390/v12111330

Ejemplares similares